We investigated the acute effects of
oral administration of
1,25-dihydroxyvitamin D (1,25-(OH)2D) and
phosphate on the major
mineral metabolism indexes in six children with
vitamin D-resistant rickets treated with a long-term regimen of
phosphate and
calcitriol. Two acute tests were performed in which plasma
calcium, phosphate, immunoreactive
parathyroid hormone (iPTH) (intact molecule),
25-hydroxyvitamin D (25-OHD), and 1,25-(OH)2D levels were measured: the first after an oral
phosphate load (20 mg/kg) was administered after
calcitriol had been discontinued for 10 days, and the second after a
calcitriol load (0.03 microgram/kg) plus the same
phosphate load but with the children receiving the usual combination treatment. There were no significant differences in basal levels of
calcium, phosphate, iPTH, 25-OHD, or 1,25-(OH)2D between the two tests, nor were delta percent
calcium and 25-OHD values significantly different. The delta percent plasma
phosphate concentration at 60 minutes was significantly higher during test 2 than during test 1 (p less than 0.01) and delta percent iPTH concentration at 60 minutes was significantly higher during test 1 than during test 2 (p less than 0.01). In test 2 the iPTH level returned to baseline at 180 minutes. Higher delta percent 1,25-(OH)2D values at 60 minutes were observed in test 2 than in test 1 (p less than 0.01). Furthermore, the delta percent 1,25-(OH)2D levels were still higher at 180 minutes in test 2 than during test 1 (p less than 0.01). Our study indicates that oral
calcitriol has an inhibitory effect on iPTH secretion in the hours immediately after oral
phosphate administration in children with
vitamin D-resistant rickets.